Lang Ngo - Concepedia

Author

Lang Ngo

Memorial Sloan Kettering Cancer Center

Also Known As

L Ngo, L. Ngo, Lang Ngo

Publications

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Columbia University Cornell University Kettering University

About

Lang Ngo is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	2.1K
2	Natural Sciences	5	5	1.2K
3	Biochemistry	4	4	783
4	Health Sciences	1	1	14
5	Biomolecular Engineering	1	1	64

Lang Ngo

Publications

Citations

H-Index

Page 1

	Year	Citations
Histone deacetylase (HDAC) inhibitor activation of p21 <sup>WAF1</sup> involves changes in promoter-associated proteins, including HDAC1 C. Gui, Lang Ngo, Weili Xu, Proceedings of the National Academy of Sciences Histone ModificationsEpigenetic ChangeGeneticsMolecular BiologyEpigenetics	2004	549
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors Johanna Ungerstedt, Yoshihiro Sowa, Weili Xu, Proceedings of the National Academy of Sciences Chemoprevention StrategyApoptosisCell DeathOxidative StressDeacetylase Inhibitors	2005	504
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Victoria M. Richon, Yael Webb, R Merger, Proceedings of the National Academy of Sciences Chemoprevention StrategyHybrid Polar CompoundsCell DifferentiationCell SpecializationPotent Inducers	1996	420
Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair J.-H. Lee, Megan L. Choy, Lang Ngo, Proceedings of the National Academy of Sciences	2010	376
Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents Mandana Namdar, Gisela Perez, Lang Ngo, Proceedings of the National Academy of Sciences Histone ModificationsHdac6 InhibitionDna DamageEpigenetic ChangeApoptosis	2010	201
Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor Weisheng Xu, Lang Ngo, Gisela Perez, Proceedings of the National Academy of Sciences ApoptosisCell DeathReactive Oxygen SpeciesCancer BiologyOxidative Stress	2006	179
Development of a histone deacetylase 6 inhibitor and its biological effects Ju‐Hee Lee, Adaickapillai Mahendran, Yuanshan Yao, Proceedings of the National Academy of Sciences	2013	132
Induction of Polyploidy by Histone Deacetylase Inhibitor: A Pathway for Antitumor Effects Weisheng Xu, Gisela Perez, Lang Ngo, Cancer Research	2005	120
Histone deacetylase inhibitors selectively suppress expression of HDAC7 Milos Dokmanovic, Gisela Perez, Weisheng Xu, Molecular Cancer Therapeutics	2007	97
Mumps Antibody Levels Among Students Before a Mumps Outbreak: In Search of a Correlate of Immunity Margaret M. Cortese, Albert E. Barskey, Gary E. Tegtmeier, The Journal of Infectious Diseases	2011	84

Page 1